-
Sector Analysis
NewUnited Kingdom (UK) Bedroom Textiles Market Trends, Analysis, Consumer Dynamics and Spending Habits
The UK: Home Category Data, The Consumer – Bedroom textiles report offers a comprehensive insight into consumer attitudes in the UK Bedroom textiles market. The report focuses on five key subcategories: overall Bedroom textiles, Pillows & duvets, Covers, Blankets, Sheets, and Bedroom accessories. Consumer data is based on our 2023 UK bedroom textiles survey, using a panel of 2,000 nationally representative consumers.
-
Thematic Analysis
NewCybersecurity in Sport – Thematic Intelligence
Cybersecurity in Sport Thematic Intelligence Report Overview The business of sport naturally accrues a large amount of sensitive data. Sports teams, federations, broadcasters, and sponsors are all vulnerable to attacks due to their significant revenues, the exposure any attack will receive, and the multiple entry points that result from their distributed communications. Events and international bodies provide a global stage for hackers. Nation-state-sponsored attacks have occurred in the sports industry, usually in response to regulations and sanctions against countries and...
-
Sector Analysis
NewUnited Kingdom (UK) Home Living Room Textiles Market Trends, Analysis, Consumer Dynamics and Spending Habits
The UK: Home Category Data, The Consumer – Living room textiles report offers a comprehensive insight into consumer attitudes in the UK living room textiles market. The report focuses on five key subcategories: overall living room textiles, cushions & cushion covers, sofa covers & throws, and beanbags. Consumer data is based on our 2023 UK Living room textiles survey, using a panel of 2,000 nationally representative consumers.
-
Thematic Analysis
NewCybersecurity in Automotive – Thematic Intelligence
Cybersecurity in Automotive Thematic Report Overview Cybersecurity is crucial for all automotive businesses to prevent hackers from compromising the safety and advanced driver assistance systems (ADAS) of a vehicle in use or, worse, manipulating any autonomous functionality to directly cause a crash. At a higher level, automotive companies are also at risk of industrial cybercrime, such as the theft of valuable tech secrets or damage to their digital infrastructure. The ‘Cybersecurity in Automotive’ thematic intelligence report provides insights into the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Teserpaturev in Malignant Pleural Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Teserpaturev in Malignant Pleural Mesothelioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Teserpaturev in Malignant Pleural Mesothelioma Drug Details: Teserpaturev (Delytact) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lenvatinib Mesylate in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lenvatinib Mesylate in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lenvatinib Mesylate in Metastatic Melanoma Drug Details: Lenvatinib mesylate (Lenvima...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lenvatinib Mesylate in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lenvatinib Mesylate in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lenvatinib Mesylate in Non-Small Cell Lung Cancer Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lenvatinib Mesylate in Rhabdomyosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lenvatinib Mesylate in Rhabdomyosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lenvatinib Mesylate in Rhabdomyosarcoma Drug Details: Lenvatinib mesylate (Lenvima / Kisplyx...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lenvatinib Mesylate in High-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lenvatinib Mesylate in High-Grade Glioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lenvatinib Mesylate in High-Grade Glioma Drug Details: Lenvatinib mesylate (Lenvima...